WOONSOCKET – CVS Health Corp. last week entered into an agreement to sell $3.5 billion of senior notes.
The deal, made with Barclays Capital Inc. and Merrill Lynch, Pierce, Fenner & Smith Inc., included an agreement for CVS to sell $1.7 billion aggregate principal amount of its 2.125 percent senior notes to the underwriters due June 1, 2021, according to a federal filing. An addition $1.7 billion aggregate principal amount of the company’s 2.875 percent senior notes were sold due June 1 2026.
The closing is set for May 25.
No posts to display
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.